CAM
COLL icon

ClariVest Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

ClariVest Asset Management’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-63,566
Closed -$1.13M – 697
2022
Q2 		$1.13M Hold
63,566
– – 0.05% 258
2022
Q1 		$1.29M Buy
63,566
+28,766
+83% +$543K 0.05% 260
2021
Q4 		$650K Sell
34,800
-600
-2% -$11.7K 0.02% 396
2021
Q3 		$699K Sell
35,400
-300
-0.8% -$6.49K 0.02% 379
2021
Q2 		$844K Hold
35,700
– – 0.03% 326
2021
Q1 		$846K Buy
35,700
+1,900
+6% +$45.1K 0.03% 307
2020
Q4 		$677K Sell
33,800
-698
-2% -$13.6K 0.02% 329
2020
Q3 		$718K Sell
34,498
-2,100
-6% -$37.9K 0.02% 326
2020
Q2 		$641K Sell
36,598
-10,144
-22% -$199K 0.02% 367
2020
Q1 		$763K Buy
46,742
+7,142
+18% +$147K 0.02% 339
2019
Q4 		$815K Sell
39,600
-400
-1% -$6.67K 0.02% 377
2019
Q3 		$459K Sell
40,000
-200
-0.5% -$2.28K 0.01% 420
2019
Q2 		$529K Buy
+40,200
New +$538K 0.01% 362

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

ClariVest Asset Management's COLL Position: Q3 2022 in Review

ClariVest Asset Management sold out of Collegium Pharmaceutical (COLL) in Q3 2022, closing a stake of 63,566 shares — an estimated $1.13M sold.

ClariVest Asset Management first reported a position in COLL in Q2 2019 and held it in 13 quarters. The position peaked at $1.29M in Q1 2022. 168 funds tracked by Wall St. Rank hold COLL as of Q3 2022.

  • ClariVest Asset Management reported no remaining Collegium Pharmaceutical position as of Q3 2022 after selling out during the quarter.
  • ClariVest Asset Management sold 63,566 Collegium Pharmaceutical shares in Q3 2022, an estimated $1.13M.
  • ClariVest Asset Management first reported a position in Collegium Pharmaceutical in Q2 2019 and held it in 13 quarters.
  • ClariVest Asset Management's Collegium Pharmaceutical position peaked at $1.29M in Q1 2022.
  • 168 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2022.

Based on ClariVest Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.